AstraZeneca (Zoladex commercial rights) Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

AstraZeneca (Zoladex commercial rights) General Information

Description

The commercial distribution rights of Zoladex in the United States of America and Canada. The rights are that of an injectable luteinising hormone-releasing hormone agonist, used to treat prostate cancer, breast cancer and certain benign gynaecological disorders.

Contact Information

Formerly Known As
Trushelfco (No.3251) Limited
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • 2 Kingdom Street
  • London W2 6BD
  • England, United Kingdom
Primary Industry
Distributors (Healthcare)
Vertical(s)
Corporate Office
  • 2 Kingdom Street
  • London W2 6BD
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AstraZeneca (Zoladex commercial rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AstraZeneca (Zoladex commercial rights)‘s full profile, request access.

Request a free trial

AstraZeneca (Zoladex commercial rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AstraZeneca (Zoladex commercial rights)‘s full profile, request access.

Request a free trial

AstraZeneca (Zoladex commercial rights) FAQs

  • When was AstraZeneca (Zoladex commercial rights) founded?

    AstraZeneca (Zoladex commercial rights) was founded in 2006.

  • Where is AstraZeneca (Zoladex commercial rights) headquartered?

    AstraZeneca (Zoladex commercial rights) is headquartered in London, United Kingdom.

  • What industry is AstraZeneca (Zoladex commercial rights) in?

    AstraZeneca (Zoladex commercial rights)’s primary industry is Distributors (Healthcare).

  • Is AstraZeneca (Zoladex commercial rights) a private or public company?

    AstraZeneca (Zoladex commercial rights) is a Private company.

  • What is the current valuation of AstraZeneca (Zoladex commercial rights)?

    The current valuation of AstraZeneca (Zoladex commercial rights) is .

  • What is AstraZeneca (Zoladex commercial rights)’s current revenue?

    The current revenue for AstraZeneca (Zoladex commercial rights) is .

  • Who are AstraZeneca (Zoladex commercial rights)’s investors?

    AstraZeneca has invested in AstraZeneca (Zoladex commercial rights).

  • When was AstraZeneca (Zoladex commercial rights) acquired?

    AstraZeneca (Zoladex commercial rights) was acquired on 31-Mar-2017.

  • Who acquired AstraZeneca (Zoladex commercial rights)?

    AstraZeneca (Zoladex commercial rights) was acquired by Tersera Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process